BRIEF published on 08/05/2024 at 07:05, 8 months 5 days ago Relief Therapeutics obtient jusqu'à 11 millions de dollars grâce aux ventes de redevances Développement Clinique Financement Non Dilutif Approbation De La FDA Thérapeutique De Soulagement Ventes De Redevances
PRESS RELEASE published on 08/05/2024 at 07:00, 8 months 5 days ago Relief Therapeutics Secures up to $11 Million from Royalty Sales Relief Therapeutics secures $11 million from royalty sales for RLF-TD011 clinical development and pipeline advancement. Funding from SWK Holdings Corporation to support rare disease treatment options SWK Holdings Corporation Clinical Development Relief Therapeutics Rare Diseases Royalty Sales
BRIEF published on 06/27/2024 at 12:50, 9 months 13 days ago Relief Therapeutics Holding SA publie les résultats de son assemblée générale annuelle Actionnaires Conseil D'administration États Financiers Résultats De L'AGA Thérapeutique De Soulagement
BRIEF published on 06/27/2024 at 12:50, 9 months 13 days ago Relief Therapeutics Holding SA Reports Results of Annual General Meeting Board Of Directors Shareholders Financial Statements Relief Therapeutics AGM Results
PRESS RELEASE published on 06/27/2024 at 12:45, 9 months 13 days ago RELIEF THERAPEUTICS Holding SA Announces Results of Annual General Meeting RELIEF THERAPEUTICS Holding SA announces the results of its Annual General Meeting of Shareholders in Geneva. Details on approved resolutions and election outcomes Annual General Meeting Shareholders Resolutions RELIEF THERAPEUTICS Holding SA Geneva
BRIEF published on 06/03/2024 at 07:05, 10 months 7 days ago Relief Therapeutics Announces Executive Changes Board Of Directors Executive Changes Biopharmaceutical Relief Therapeutics Senior Management
BRIEF published on 06/03/2024 at 07:05, 10 months 7 days ago Relief Therapeutics annonce des changements à la direction Conseil D'administration Biopharmaceutique Changements De Direction Thérapeutique De Soulagement La Haute Direction
PRESS RELEASE published on 06/03/2024 at 07:00, 10 months 7 days ago Relief Therapeutics Announces Executive Changes Relief Therapeutics announces executive changes as interim CEO Michelle Lock completes her mandate and transitions out, along with other key executives. Board to review management for optimal results Executive Changes Biopharmaceutical Relief Therapeutics Rare Diseases Management Review
BRIEF published on 05/30/2024 at 07:05, 10 months 11 days ago Relief Therapeutics annonce l'avis de convocation à l'assemblée générale annuelle des actionnaires Biopharmaceutique AGA 2024 Thérapeutique De Soulagement Rencontre D'actionnaires Genève
BRIEF published on 05/30/2024 at 07:05, 10 months 11 days ago Relief Therapeutics Announces Notice of Annual General Meeting of Shareholders Biopharmaceutical Relief Therapeutics AGM 2024 Shareholders Meeting Geneva
Published on 04/10/2025 at 19:00, 1 hour 19 minutes ago D. Boral Capital Acted as Sole Bookrunner to FatPipe, Inc. (Nasdaq: FATN) in Connection with its $4.0 Million Initial Public Offering
Published on 04/10/2025 at 15:15, 5 hours 4 minutes ago ReelTime’s Reel Intelligence "RI" Outperforms AI While Requiring a Fraction of The Resources
Published on 04/10/2025 at 15:00, 5 hours 19 minutes ago Route1 Signs Significant New Orders with Major Cities in the Southwestern United States and Announces Key Corporate Updates Including Its Acquisition Growth Strategy
Published on 04/10/2025 at 15:00, 5 hours 19 minutes ago Inspire Veterinary Partners Announces Attendance at Upcoming Investor Events
Published on 04/10/2025 at 15:00, 5 hours 19 minutes ago Xebra Brands Launches National RFP to Establish Cannabis Cultivation Partnerships Across Mexico
Published on 04/10/2025 at 19:00, 1 hour 19 minutes ago Immunic, Inc. Announces Closing of $5.1 Million Registered Direct Offering, Led by Aberdeen Investments
Published on 04/10/2025 at 18:57, 1 hour 22 minutes ago EQS-Adhoc: HAMBORNER REIT AG: Adjustment of dividend strategy
Published on 04/10/2025 at 18:15, 2 hours 4 minutes ago EQS-Adhoc: SCHOTT Pharma AG & Co. KGaA: SCHOTT Pharma: Preliminary Q2 2025 figures exceed capital market expectations
Published on 04/10/2025 at 18:04, 2 hours 15 minutes ago Modalités de mise à disposition du Rapport sur la solvabilité et la situation financière 2024 du Groupe des Assurances du Crédit Mutuel
Published on 04/10/2025 at 18:03, 2 hours 16 minutes ago Mise à disposition des états financiers 2024 du Groupe des Assurances du Crédit Mutuel
Published on 04/10/2025 at 18:00, 2 hours 19 minutes ago SMTPC - Communiqué sur le Chiffre d'affaires du 1er trimestre 2025
Published on 04/10/2025 at 17:45, 2 hours 34 minutes ago EURAZEO INVESTIT DANS EKOSCAN INTEGRITY, ACTEUR DE REFERENCE DANS LES SOLUTIONS AVANCEES DE CONTROLE NON DESTRUCTIF POUR APPLICATIONS INDUSTRIELLES ET INFRASTRUCTURES CRITIQUES
